The Technical Analyst
Moringa Acquisition Corp [MACAU]
Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies
Moringa Acquisition Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.43% $10.97
/ 4 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 43.00 mill |
| EPS: | -0.0610 |
| P/E: | -179.84 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 3.92 mill |
| Avg Daily Volume: | 0.0000 mill |
| RATING 2024-04-04 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -179.84 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -179.84 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.82 - 11.12 ( +/- 1.40%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-08-22 | Hudson Bay Capital Management Lp | Sell | 401 271 | Class A Ordinary Shares, par value $0.0001 per share |
| 2023-02-09 | Hudson Bay Capital Management Lp | Buy | 0 | Class A Ordinary Shares, $0.0001 par value |
| INSIDER POWER |
|---|
| -100.00 |
| Last 1 transactions |
| Buy: 0 | Sell: 401 271 |
Forecast:
01:40 - $10.71
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.97 (2.43% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0.0000 mill |
| % of Avg. Vol | 22.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MACAU
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MACAU
Moringa Acquisition Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.
Latest Press Releases
2024-02-22 08:27:00 - Press Release
Silexion, A Clinical-stage, Oncology-focused Biotechnology Company, To Become Publicly Traded Via Business Combination With Moringa Acquisition Corp
Moringa acquisition corp (nasdaq: maca) (“moringa”), a special purpose acquisition company, today announced it has entered into a business combination agreement with silexion ltd. (“silexion”), a clinical-stage, oncology-focused biotechnology company, that would result in silexion becoming publicly listed on the nasdaq. the business combination provides for silexion's pre-transaction equity value to be $62.5 million, based on a $10 share price.
2023-08-15 09:25:00 - Press Release
Moringa Acquisition Corp Announces Contribution To Trust Account In Connection With Proposed Extension
New york, ny, aug. 15, 2023 (globe newswire) -- moringa acquisition corp (nasdaq: maca) (“moringa” or the “company”) announced today that, in connection with its previously announced extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders of the company to be held at 9:00 a.m. eastern time/4:00 p.m. local (israel) time on august 16, 2023 (the “extraordinary meeting”) for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the company must consummate an initial business combination (the “extension”) from august 19, 2023 (the “current termination date”) to august 19, 2024 or such earlier date as may be determined by the company's board of directors, in its sole discretion (such new termination date, the “extension date”), the company's sponsor, moringa sponsor, l...